-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AkWWEaTrE9NJJ5f4lCbzsI4hrZEEDzjQLWiMuw5TIM+HRws2VCqHlrMZrsNeNqJ+ 53vVxa+KIHtwaOhFYQwZEA== 0001179110-06-011293.txt : 20060518 0001179110-06-011293.hdr.sgml : 20060518 20060518155037 ACCESSION NUMBER: 0001179110-06-011293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060516 FILED AS OF DATE: 20060518 DATE AS OF CHANGE: 20060518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REILLY PHILIP R CENTRAL INDEX KEY: 0001237194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 06852129 MAIL ADDRESS: STREET 1: C/O INTERLEUKIN GENETICS INC STREET 2: 135 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02452 4 1 edgar.xml FORM 4 - X0202 4 2006-05-16 0 0001037649 INTERLEUKIN GENETICS INC ILI 0001237194 REILLY PHILIP R 135 BEAVER STREET WALTHAM MA 02452 1 0 0 0 Common Stock 2006-05-16 4 M 0 8000 0.50 A 18000 D Common Stock 2006-05-16 4 S 0 8000 5.82 D 10000 D Common Stock 73275 I See Footnote Option to Buy (Common Stock) 0.50 2006-05-16 4 M 0 8000 0.00 D 1999-12-01 2009-05-31 Common Stock 8000 189000 D Pursuant to a 10b5-1 Trading Plan entered into on May 15, 2006. Shares are held in irrevocable trusts for the benefit of Dr. Reilly's children. Dr. Reilly disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purposes. Closing price on AMEX on May 16, 2006 5,000 of these shares were exercisable on 12/1/99, and 3,000 shares were exercisable on 1/1/00. /s/ Philip R. Reilly 2006-05-17 -----END PRIVACY-ENHANCED MESSAGE-----